
AACR Virtual Meeting on COVID-19 and Cancer: “Lightspeed” Vaccine Development—How Did They Do It?
On December 31, 2019, the first cases of “a pneumonia of unknown cause”—now known to be COVID-19—were reported in China, and the initial confirmed...
Home »
On December 31, 2019, the first cases of “a pneumonia of unknown cause”—now known to be COVID-19—were reported in China, and the initial confirmed...
Racial/ethnic inequities in cancer are well documented. Not only are Black Americans more likely to die of cancer than white Americans, but Black and Hispanic individuals are...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a grim prognosis. While early-stage PDAC may be removed by...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
The screen goes blue, that unmistakable tune starts playing, and the voice of Johnny Gilbert announces, “This. Is. Jeopardy!” We meet the contestants. We hear...
The 2020 Nobel Prize in Chemistry was awarded to Fellows of the AACR Academy Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, for their groundbreaking development of the CRISPR-Cas9 genome editing system. This technology allows researchers to accurately delete,...
Immune checkpoint inhibition is a form of cancer immunotherapy that works by releasing the “brakes” on the immune system, thereby increasing...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...